The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...
The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
Research shows that Blacks may develop multiple sclerosis more often than previously thought. Additionally, the symptoms of ...
A new study from Norway found a 42% lower risk of developing MS among women with greater dietary vitamin D intake, ...
NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...
Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...
BUFFALO, N.Y. -- Pediatric multiple sclerosis researchers at the University at Buffalo are working to define and better understand previously unappreciated and uncommon types of childhood ...
Researchers have identified a new subtype of multiple sclerosis that affects thinking and memory rather than mobility — and as many as 26 percent of people with MS may have it. Researchers have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback